First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey. Issue 8 (August 2015)
- Record Type:
- Journal Article
- Title:
- First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey. Issue 8 (August 2015)
- Main Title:
- First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey
- Authors:
- Özmerdiven, Gülşah Ece
Ak, Seçil
Ener, Beyza
Ağca, Harun
Cilo, Burcu Dalyan
Tunca, Berrin
Akalın, Halis - Abstract:
- <abstract xml:lang="en" abstract-type="author" id="abs0010"> <title id="sectitle0010">Abstract</title> <sec> <p id="abspara0010"> <italic>Aspergillus fumigatus</italic> is the most important etiological agent of invasive aspergillosis. Recently, an increasing number of azole-resistant <italic>A. fumigatus</italic> isolates have been described in various countries. The prevalence of azole resistance was investigated in this study using our culture collection of <italic>A. fumigatus</italic> isolates collected between 1999 and 2012 from clinical specimens. Seven hundred and forty-six <italic>A. fumigatus</italic> isolates, collected from 419 patients, were investigated. First, all isolates were screened for resistance to itraconazole by subculturing on Sabouraud dextrose agar that contained 4 mg/L itraconazole. For isolates that grew on the itraconazole containing agar, the in vitro activities of amphotericin B, itraconazole, voriconazole and posaconazole were determined using the Clinical and Laboratory Standards Institute (CLSI) M38-A reference method. After PCR amplification, the full sequence of the <italic>cyp51A</italic> gene and its promoter region was determined for all in vitro azole-resistant isolates. Itraconazole resistance was found in 10.2% of the <italic>A. fumigatus</italic> isolates. From 2000 onwards, patients were observed annually with an itraconazole-resistant isolate. According to in vitro susceptibility tests, amphotericin B exhibited good activity<abstract xml:lang="en" abstract-type="author" id="abs0010"> <title id="sectitle0010">Abstract</title> <sec> <p id="abspara0010"> <italic>Aspergillus fumigatus</italic> is the most important etiological agent of invasive aspergillosis. Recently, an increasing number of azole-resistant <italic>A. fumigatus</italic> isolates have been described in various countries. The prevalence of azole resistance was investigated in this study using our culture collection of <italic>A. fumigatus</italic> isolates collected between 1999 and 2012 from clinical specimens. Seven hundred and forty-six <italic>A. fumigatus</italic> isolates, collected from 419 patients, were investigated. First, all isolates were screened for resistance to itraconazole by subculturing on Sabouraud dextrose agar that contained 4 mg/L itraconazole. For isolates that grew on the itraconazole containing agar, the in vitro activities of amphotericin B, itraconazole, voriconazole and posaconazole were determined using the Clinical and Laboratory Standards Institute (CLSI) M38-A reference method. After PCR amplification, the full sequence of the <italic>cyp51A</italic> gene and its promoter region was determined for all in vitro azole-resistant isolates. Itraconazole resistance was found in 10.2% of the <italic>A. fumigatus</italic> isolates. From 2000 onwards, patients were observed annually with an itraconazole-resistant isolate. According to in vitro susceptibility tests, amphotericin B exhibited good activity against all isolates whereas the azoles were resistant. Sequence analysis of the promoter region and <italic>CYP51A</italic> gene indicated the presence of TR34/L98H in 86.8% (n = 66) of isolates. This initial analysis of the resistance mechanism of <italic>A. fumigatus</italic> from Turkey revealed a common TR34/L98H mutation in the <italic>cyp51A</italic> gene.</p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of infection and chemotherapy. Volume 21:Issue 8(2015:Aug.)
- Journal:
- Journal of infection and chemotherapy
- Issue:
- Volume 21:Issue 8(2015:Aug.)
- Issue Display:
- Volume 21, Issue 8 (2015)
- Year:
- 2015
- Volume:
- 21
- Issue:
- 8
- Issue Sort Value:
- 2015-0021-0008-0000
- Page Start:
- 581
- Page End:
- 586
- Publication Date:
- 2015-08
- Subjects:
- Chemotherapy -- Periodicals
Infection -- Periodicals
Communicable diseases -- Chemotherapy -- Periodicals
615.5805 - Journal URLs:
- http://www.sciencedirect.com/science/journal/1341321X ↗
http://link.springer-ny.com/link/service/journals/10156/index.htm ↗
http://www.springerlink.com/content/1341-321x ↗
http://www.elsevier.com/journals ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1016/j.jiac.2015.04.012 ↗
- Languages:
- English
- ISSNs:
- 1341-321X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5006.691000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3892.xml